The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Genetic Engineering Drug Market Research Report 2024

Global Genetic Engineering Drug Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1554851

No of Pages : 85

Ask Your Query

Synopsis

Genetic Engineering Drug is also called Genetic Engineering or Genetic manipulation, and is the direct manipulation of an organism's genes using the Drug required in biotechnology.

The global Genetic Engineering Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Genetic Engineering Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Genetic Engineering Drug.

Report Scope

The Genetic Engineering Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Genetic Engineering Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Genetic Engineering Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

By Company

  • Shanghai Lansheng Guojian Pharmaceutical
  • Biotech Pharmaceutical
  • Anhui Anke Biotechnology
  • GeneScience Pharmaceuticals
  • Beijing SL Pharmaceutical
  • Jiangsu Sihuan Bioengineering
  • Shenzhen Neptunus Interlong Bio-Technique
  • 3SBio
  • Tonghua Dongbao Pharmaceutical

Segment by Type

  • Monoclonal Antibody
  • Recombinant Human Erythropoietin
  • Recombinant Human Interferon
  • Recombinant Human Growth Hormone
  • Recombinant Human Insulin

Segment by Application

  • Medicine
  • Research
  • Industrial
  • Agriculture
  • Other

Consumption by Region

  •     North America (United States, Canada)
  •     Europe (Germany, France, U.K., Italy, Russia)
  •     Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  •     Latin America (Mexico, Brazil, Argentina)
  •     Middle East & Africa (Turkey, Saudi Arabia, UAE)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Genetic Engineering Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Genetic Engineering Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Index

1 Genetic Engineering Drug Market Overview
1.1 Product Overview and Scope of Genetic Engineering Drug
1.2 Genetic Engineering Drug Segment by Type
1.2.1 Global Genetic Engineering Drug Market Value Comparison by Type (2024-2030)
1.2.2 Monoclonal Antibody
1.2.3 Recombinant Human Erythropoietin
1.2.4 Recombinant Human Interferon
1.2.5 Recombinant Human Growth Hormone
1.2.6 Recombinant Human Insulin
1.3 Genetic Engineering Drug Segment by Application
1.3.1 Global Genetic Engineering Drug Market Value by Application: (2024-2030)
1.3.2 Medicine
1.3.3 Research
1.3.4 Industrial
1.3.5 Agriculture
1.3.6 Other
1.4 Global Genetic Engineering Drug Market Size Estimates and Forecasts
1.4.1 Global Genetic Engineering Drug Revenue 2019-2030
1.4.2 Global Genetic Engineering Drug Sales 2019-2030
1.4.3 Global Genetic Engineering Drug Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Genetic Engineering Drug Market Competition by Manufacturers
2.1 Global Genetic Engineering Drug Sales Market Share by Manufacturers (2019-2024)
2.2 Global Genetic Engineering Drug Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Genetic Engineering Drug Average Price by Manufacturers (2019-2024)
2.4 Global Genetic Engineering Drug Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Genetic Engineering Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Genetic Engineering Drug, Product Type & Application
2.7 Genetic Engineering Drug Market Competitive Situation and Trends
2.7.1 Genetic Engineering Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Genetic Engineering Drug Players Market Share by Revenue
2.7.3 Global Genetic Engineering Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Genetic Engineering Drug Retrospective Market Scenario by Region
3.1 Global Genetic Engineering Drug Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Genetic Engineering Drug Global Genetic Engineering Drug Sales by Region: 2019-2030
3.2.1 Global Genetic Engineering Drug Sales by Region: 2019-2024
3.2.2 Global Genetic Engineering Drug Sales by Region: 2025-2030
3.3 Global Genetic Engineering Drug Global Genetic Engineering Drug Revenue by Region: 2019-2030
3.3.1 Global Genetic Engineering Drug Revenue by Region: 2019-2024
3.3.2 Global Genetic Engineering Drug Revenue by Region: 2025-2030
3.4 North America Genetic Engineering Drug Market Facts & Figures by Country
3.4.1 North America Genetic Engineering Drug Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Genetic Engineering Drug Sales by Country (2019-2030)
3.4.3 North America Genetic Engineering Drug Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Genetic Engineering Drug Market Facts & Figures by Country
3.5.1 Europe Genetic Engineering Drug Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Genetic Engineering Drug Sales by Country (2019-2030)
3.5.3 Europe Genetic Engineering Drug Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Genetic Engineering Drug Market Facts & Figures by Country
3.6.1 Asia Pacific Genetic Engineering Drug Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Genetic Engineering Drug Sales by Country (2019-2030)
3.6.3 Asia Pacific Genetic Engineering Drug Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Genetic Engineering Drug Market Facts & Figures by Country
3.7.1 Latin America Genetic Engineering Drug Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Genetic Engineering Drug Sales by Country (2019-2030)
3.7.3 Latin America Genetic Engineering Drug Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Genetic Engineering Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Genetic Engineering Drug Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Genetic Engineering Drug Sales by Country (2019-2030)
3.8.3 Middle East and Africa Genetic Engineering Drug Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Genetic Engineering Drug Sales by Type (2019-2030)
4.1.1 Global Genetic Engineering Drug Sales by Type (2019-2024)
4.1.2 Global Genetic Engineering Drug Sales by Type (2025-2030)
4.1.3 Global Genetic Engineering Drug Sales Market Share by Type (2019-2030)
4.2 Global Genetic Engineering Drug Revenue by Type (2019-2030)
4.2.1 Global Genetic Engineering Drug Revenue by Type (2019-2024)
4.2.2 Global Genetic Engineering Drug Revenue by Type (2025-2030)
4.2.3 Global Genetic Engineering Drug Revenue Market Share by Type (2019-2030)
4.3 Global Genetic Engineering Drug Price by Type (2019-2030)
5 Segment by Application
5.1 Global Genetic Engineering Drug Sales by Application (2019-2030)
5.1.1 Global Genetic Engineering Drug Sales by Application (2019-2024)
5.1.2 Global Genetic Engineering Drug Sales by Application (2025-2030)
5.1.3 Global Genetic Engineering Drug Sales Market Share by Application (2019-2030)
5.2 Global Genetic Engineering Drug Revenue by Application (2019-2030)
5.2.1 Global Genetic Engineering Drug Revenue by Application (2019-2024)
5.2.2 Global Genetic Engineering Drug Revenue by Application (2025-2030)
5.2.3 Global Genetic Engineering Drug Revenue Market Share by Application (2019-2030)
5.3 Global Genetic Engineering Drug Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Shanghai Lansheng Guojian Pharmaceutical
6.1.1 Shanghai Lansheng Guojian Pharmaceutical Corporation Information
6.1.2 Shanghai Lansheng Guojian Pharmaceutical Description and Business Overview
6.1.3 Shanghai Lansheng Guojian Pharmaceutical Genetic Engineering Drug Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Shanghai Lansheng Guojian Pharmaceutical Genetic Engineering Drug Product Portfolio
6.1.5 Shanghai Lansheng Guojian Pharmaceutical Recent Developments/Updates
6.2 Biotech Pharmaceutical
6.2.1 Biotech Pharmaceutical Corporation Information
6.2.2 Biotech Pharmaceutical Description and Business Overview
6.2.3 Biotech Pharmaceutical Genetic Engineering Drug Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Biotech Pharmaceutical Genetic Engineering Drug Product Portfolio
6.2.5 Biotech Pharmaceutical Recent Developments/Updates
6.3 Anhui Anke Biotechnology
6.3.1 Anhui Anke Biotechnology Corporation Information
6.3.2 Anhui Anke Biotechnology Description and Business Overview
6.3.3 Anhui Anke Biotechnology Genetic Engineering Drug Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Anhui Anke Biotechnology Genetic Engineering Drug Product Portfolio
6.3.5 Anhui Anke Biotechnology Recent Developments/Updates
6.4 GeneScience Pharmaceuticals
6.4.1 GeneScience Pharmaceuticals Corporation Information
6.4.2 GeneScience Pharmaceuticals Description and Business Overview
6.4.3 GeneScience Pharmaceuticals Genetic Engineering Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 GeneScience Pharmaceuticals Genetic Engineering Drug Product Portfolio
6.4.5 GeneScience Pharmaceuticals Recent Developments/Updates
6.5 Beijing SL Pharmaceutical
6.5.1 Beijing SL Pharmaceutical Corporation Information
6.5.2 Beijing SL Pharmaceutical Description and Business Overview
6.5.3 Beijing SL Pharmaceutical Genetic Engineering Drug Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Beijing SL Pharmaceutical Genetic Engineering Drug Product Portfolio
6.5.5 Beijing SL Pharmaceutical Recent Developments/Updates
6.6 Jiangsu Sihuan Bioengineering
6.6.1 Jiangsu Sihuan Bioengineering Corporation Information
6.6.2 Jiangsu Sihuan Bioengineering Description and Business Overview
6.6.3 Jiangsu Sihuan Bioengineering Genetic Engineering Drug Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Jiangsu Sihuan Bioengineering Genetic Engineering Drug Product Portfolio
6.6.5 Jiangsu Sihuan Bioengineering Recent Developments/Updates
6.7 Shenzhen Neptunus Interlong Bio-Technique
6.6.1 Shenzhen Neptunus Interlong Bio-Technique Corporation Information
6.6.2 Shenzhen Neptunus Interlong Bio-Technique Description and Business Overview
6.6.3 Shenzhen Neptunus Interlong Bio-Technique Genetic Engineering Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Shenzhen Neptunus Interlong Bio-Technique Genetic Engineering Drug Product Portfolio
6.7.5 Shenzhen Neptunus Interlong Bio-Technique Recent Developments/Updates
6.8 3SBio
6.8.1 3SBio Corporation Information
6.8.2 3SBio Description and Business Overview
6.8.3 3SBio Genetic Engineering Drug Sales, Revenue and Gross Margin (2019-2024)
6.8.4 3SBio Genetic Engineering Drug Product Portfolio
6.8.5 3SBio Recent Developments/Updates
6.9 Tonghua Dongbao Pharmaceutical
6.9.1 Tonghua Dongbao Pharmaceutical Corporation Information
6.9.2 Tonghua Dongbao Pharmaceutical Description and Business Overview
6.9.3 Tonghua Dongbao Pharmaceutical Genetic Engineering Drug Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Tonghua Dongbao Pharmaceutical Genetic Engineering Drug Product Portfolio
6.9.5 Tonghua Dongbao Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Genetic Engineering Drug Industry Chain Analysis
7.2 Genetic Engineering Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Genetic Engineering Drug Production Mode & Process
7.4 Genetic Engineering Drug Sales and Marketing
7.4.1 Genetic Engineering Drug Sales Channels
7.4.2 Genetic Engineering Drug Distributors
7.5 Genetic Engineering Drug Customers
8 Genetic Engineering Drug Market Dynamics
8.1 Genetic Engineering Drug Industry Trends
8.2 Genetic Engineering Drug Market Drivers
8.3 Genetic Engineering Drug Market Challenges
8.4 Genetic Engineering Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock